Nevada
|
001-37854
|
99-0367049
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
101 Glacier Point, Suite A
|
San Rafael
|
California
|
94901
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value per share
|
EKSO
|
Nasdaq Capital Market
|
Exhibit Number
|
Description
|
|
23.1
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
EKSO BIONICS HOLDINGS, INC.
|
|||
By:
|
/s/ Jerome Wong
|
||
Name:
|
Jerome Wong
|
||
Title:
|
Chief Financial Officer
|
||
Dated: January 10, 2024 |
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
We hereby consent to the incorporation by reference in Ekso Bionics Holdings, Inc.’s Registration Statement on Form S-3 (No. 333-272607) of our report dated February 16, 2023, relating to the abbreviated financial statements of the Human Motion and Control product of Parker Hannifin Corporation as of and for the years ended June 30, 2022 and 2021, included in the Current Report on Form 8-K/A of Ekso Bionics Holdings, Inc. dated February 16, 2023.
We also consent to the reference to our firm under the heading “Experts” in the prospectus supplement which is a part of the prospectus dated June 20, 2023 (No. 333-272607).
/s/ WithumSmith+Brown, PC
San Francisco, California
January 10, 2024